首頁 > 市場調查報告書 > 製藥

處方藥

市場調查報告書

商品編碼

1791244

五氟利多市場報告：2031 年趨勢、預測與競爭分析

Penfluridol Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年08月14日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

全球五氟利多市場前景光明，醫院、診所和藥局市場都蘊藏著巨大的機會。預計2025年至2031年期間，全球五氟利多市場的複合年成長率將達到2.1%。該市場的主要驅動力包括思覺失調症患者數量的增加、對長期抗精神病藥物需求的不斷成長，以及對精神健康治療的日益關注。

Lucintel 預測，在預測期內，錠劑將成為成長最快的類型。
以用途類型來看，醫院預計將出現最高的成長。
按地區分類，預計亞太地區將在預測期內實現最高成長。

一份全面的 150 多頁報告提供了寶貴的見解，為您的業務決策提供參考。

五氟利多市場的新趨勢

五氟利多市場受到許多新趨勢的影響，這些新趨勢超越了其作為抗精神病藥物的傳統用途，受到新研究發現（特別是藥物再利用）以及對精神健康治療中有效、方便、長效治療方案的持續需求的推動。

腫瘤學藥物再利用：五氟利多在癌症治療中的再利用正在迅速增加。研究表明，它透過不同的機制在包括乳癌、神經膠母細胞瘤細胞株中表現出抗腫瘤活性，使其成為潛在的新型抗癌藥物。
基於奈米粒子的遞送系統：基於奈米粒子的遞送系統正在用於五氟利多的研究，此舉旨在提高生物有效性，促進靶向遞送，並擴大其用途，特別是在常規製劑無效的難治性病例中。
口服長效依從性重點：五氟利多是一種每週口服一次的長效抗精神病藥，在提高依從性方面越來越受到關注，尤其是對於拒絕注射長效製劑的患者。
原料藥生產和出口成長：五氟利多原料藥的生產和出口正在上升，尤其是來自印度和中國等國家。
智慧財產權和生物相似藥活動：五氟利前驅藥物的專利申請數量不斷增加反映了持續的研發投入，表明隨著關鍵專利的成熟，生物相似藥和學名藥之間可能會存在競爭，從而影響市場動態和准入。

這些趨勢正在重新定義五氟利多的市場，顯著拓展其在傳統抗精神病藥物以外的治療應用，尤其是在腫瘤治療領域。創新的給藥機制、更強的口服依從性、全球化的原料藥生產以及對智慧財產權活動的重視，為這種成熟藥物帶來了令人興奮的新機會。

五氟利多市場的最新趨勢

儘管五氟利多市場已經成熟，但仍面臨一些新興趨勢，這些趨勢將影響其用途和未來發展潛力。這些趨勢的促進因素包括：即將進行的針對新型治療用途（尤其是在腫瘤學領域）的研究，以及國際藥品生產和分銷的變化。

發現抗癌活性：在各種癌細胞細胞株中發現五氟利多具有強大的抗腫瘤活性，激發了人們對腫瘤學領域藥物再利用的研究興趣。
原料藥產量成長：五氟利多原料藥(API) 的製造和出口顯著成長，尤其是來自印度和中國，瞄準國際非專利市場並增加其供應。
奈米粒子遞送系統研究：目前正在研究基於奈米粒子的遞送系統，以提高五氟利多的療效並在難治性疾病中尋找新的應用。
前驅藥物專利申請：過去幾年，五氟利前驅藥物專利申請的增加反映了對研發的持續支出，並表明了人們對改善藥理特性和市場獨佔性的興趣。
在抗治療性思覺失調症中的作用：在多個市場上都有臨床和現實世界的證據支持五氟利多對抗治療性思覺失調症特定患者群體的療效，從而推動了對這種專門適應症的需求。

這些重要進展正在對五氟利多市場產生重大影響，為其在腫瘤治療中作為抗精神病藥物的傳統用途開闢了新的治療可能性。原料藥生產、給藥技術和智慧財產權方面的創新為五氟利多帶來了新的機遇，有可能推動其在特定細分領域的更廣泛認可和市場准入。

The future of the global penfluridol market looks promising with opportunities in the hospital, clinic, and pharmacy markets. The global penfluridol market is expected to grow with a CAGR of 2.1% from 2025 to 2031. The major drivers for this market are the increasing cases of chronic schizophrenia, the rising demand for long-term antipsychotics, and the growing focus on mental health treatment.

Lucintel forecasts that, within the type category, tablets are expected to witness higher growth over the forecast period.
Within the application category, hospitals are expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Penfluridol Market

The market for penfluridol is affected by a number of emerging trends that reach beyond its classic application as an antipsychotic. They are fueled by new discoveries from research, more specifically in drug repurposing, and the constant demand for effective and easy long-acting treatment solutions in mental health treatment.

Drug Repurposing in Oncology: There is a robust upsurge in the repurposing of penfluridol in cancer therapies. Studies point to its anti-tumor activity in a range of cancer cell lines such as breast, pancreatic, and glioblastoma via differing mechanisms, making it a candidate for a new anti-cancer drug.
Nanoparticle-Based Delivery Systems: Nanoparticle-based delivery systems are being researched for penfluridol. This is a trend that seeks to increase its bioavailability, facilitate targeted delivery, and possibly extend its uses, especially in refractory cases where conventional formulations are less effective.
Oral Long-Acting Adherence Focus: Penfluridol's status as an oral long-acting antipsychotic with a weekly dosing regimen is receiving increased interest for its ability to enhance patient compliance, particularly for those patients who refuse injectable long-acting preparations.
API Production and Export Growth: There is a significant trend towards the growth of penfluridol active pharmaceutical ingredient (API) production and export, particularly from nations such as India and China, due to worldwide demand for cost-efficient and dependable long-acting oral antipsychotics.
Intellectual Property and Biosimilar Activity: The upswing in filings on patents for penfluridol prodrugs reflects continued research and development investment. This implies a future trend of potential biosimilar or generic competition as major patents mature, impacting market dynamics and access.

These trends are collectively redefining the penfluridol market by vastly expanding its therapeutic application beyond its conventional antipsychotic role, especially into oncology. The emphasis on new delivery mechanisms, enhancing oral compliance, worldwide API manufacturing, and intellectual property activity indicates a vibrant landscape with fresh opportunities for this mature drug.

Recent Developments in the Penfluridol Market

The penfluridol market, though mature, is facing some recent trends that are affecting its application and potential future. These trends are mostly influenced by upcoming research into novel therapeutic uses, especially in oncology, and changes in international pharmaceutical production and distribution.

Anticancer Activity Discovery: One key development is the discovery of penfluridol's potent anti-tumor activities in different cancer cell lines, which has generated growing research interest in the oncology repurposing of drugs.
Growth in API Production: There has been appreciable growth in penfluridol active pharmaceutical ingredient (API) manufacturing and exportation, especially from India and China, targeting international generic markets and raising accessibility.
Nanoparticle Delivery Research: Current research is aimed at creating nanoparticle-based delivery systems for penfluridol with the hope of increasing its efficacy and possibly finding new uses for it in refractory conditions.
Patent Filings for Prodrugs: An increase in patent filings for penfluridol prodrugs over the past few years reflects continued research and development spending, indicating an interest in enhancing its pharmacological characteristics and providing market exclusivity.
Role in Treatment-Resistant Schizophrenia: Clinical and real-world evidence in a few markets are underpinning penfluridol's effectiveness in a niche of treatment-resistant schizophrenia patients, expanding demand for this particular indication.

These are pivotal advancements that are strongly influencing the penfluridol market by opening new potential therapeutic applications beyond its historic antipsychotic use in oncology. The innovation of API manufacturing, delivery technologies, and intellectual property suggests renewed activity in penfluridol, possibly sparking its wider acceptance and market appearance in certain niches.

Strategic Growth Opportunities in the Penfluridol Market

The penfluridol market, though mostly recognized for its antipsychotic activity, offers strategic growth opportunities through the discovery and development of its potential in new therapeutic uses. Targeting these new areas can unlock tremendous market growth and reposition the drug beyond its existing main use.

Targeting Treatment-Resistant Cancers: The development of penfluridol as a new therapeutic compound for treatment-resistant cancers, especially those where it has been demonstrated to have substantial anti-tumor effects such as glioblastoma and triple-negative breast cancer, is a significant opportunity for growth.
Adjunctive Therapy in Oncology: Exploration of penfluridol as an adjunctive therapy to augment the effectiveness of current chemotherapy or immunotherapy regimens in cancer therapy based on its synergistic anti-tumor actions.
Managing Schizophrenia Non-Adherence: Highlighting penfluridol's benefit as an oral long-acting antipsychotic for patients with poor compliance to daily oral medication or those who reject injectable long-acting formulations, offering a convenient option.
Behavioral Symptoms in Dementia: Investigating and clinically confirming penfluridol's potential in the management of severe behavioral and psychological symptoms of dementia, where its long-acting oral profile may provide advantages for patient and caregiver convenience.
New Drug Delivery for Refractory Cases: Formulating new drug delivery systems, including nanoparticle formulations, to enhance the bioavailability and targeted delivery of penfluridol for refractory cases in both its historic antipsychotic and future cancer uses.

These application-based strategic growth opportunities are affecting the penfluridol market by radically transforming its scope from conventional psychiatric applications, with a dominant focus on oncology. The investigation into adjunctive therapy, niche applications in mental health, and new delivery systems reflects an earnest attempt to take penfluridol's therapeutic value to the maximum and increase its market reach.

Penfluridol Market Driver and Challenges

The penfluridol market is affected by a distinctive combination of factors that are both major drivers for its application and significant challenges for its expansion and extensive usage. They are its pharmacological profile, economic factors, and advancing scientific findings that are reformulating its perceived value and potential.

The factors responsible for driving the penfluridol market include:

1. Long-Acting Oral Administration: An important impetus is penfluridol's long-acting oral pharmacokinetic profile, making it possible to administer once a week, significantly enhancing patient compliance to long-term medication treatment in conditions such as schizophrenia.

2. Cost-Effectiveness: Penfluridol tends to be cheaper than newer, patented long-acting injectable antipsychotics and thus becomes a cost-saving option in cost-conscious healthcare systems and for poorer patients.

3. Repurposing in Oncology: The newly emerging evidence of penfluridol's strong anti-tumor activity across different cancer cell lines has emerged as a prime driver, possibly broadening its therapeutic indications and opening up new market opportunities.

4. Established Efficacy in Schizophrenia: Although an older antipsychotic, penfluridol has established efficacy in the treatment of the positive symptoms of schizophrenia, especially for maintenance therapy, supporting its ongoing use in some clinical contexts.

5. API Production and Export: The strong active pharmaceutical ingredient (API) manufacturing base, particularly in India and China, provides a stable and low-cost supply, fueling its presence in international generic markets.

Challenges in the penfluridol market are:

1. Limited US and European Approval: Penfluridol lacks broad approval and commercialization in the US and some parts of Europe for its antipsychotic application, restricting its market penetration and recognition in these key pharmaceutical markets.

2. Newer Antipsychotics Competition: The product is subject to strong competition from newer, more extensively marketed atypical antipsychotics, particularly long-acting injectables, which tend to have a wider range of indications and a more acceptable side effect profile.

3. Side Effect Profile: As with other first-generation antipsychotics, penfluridol can be linked with extrapyramidal side effects, which can affect patient tolerability and adherence, presenting a barrier to its wider use.

The principal drivers of its long-acting oral profile, cost benefit, and new oncology uses are maintaining and potentially enhancing the penfluridol business. While challenges of its limited approval in major markets, competition from more recently approved drugs, and its side effect profile create the need for continued research and strategic positioning to maintain its relevance and therapeutic value.

List of Penfluridol Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, penfluridol companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the penfluridol companies profiled in this report include:
Hunan Dongting Pharm
Jiangsu Nhwa Pharmaceutical
Sphsine Pharm
Chongqing Qingyang Pharmaceutical
Kamp
Harbin Pharmaceutical Group
Fuhe Group
Hunan Zhongnan Pharm
Lifecare Neuro Products
Enomark

Penfluridol Market by Segment

The study includes a forecast for the global penfluridol market by type, application, and region.

Penfluridol Market by Type [Value from 2019 to 2031]:

Tablets
Capsules

Penfluridol Market by Application [Value from 2019 to 2031]:

Hospital
Clinic
Pharmacy
Others

Penfluridol Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Penfluridol Market

The penfluridol market, although niche, is witnessing changing dynamics with its novel long-acting oral profile for schizophrenia treatment and growing research into new therapeutic uses. Recent trends indicate regional differences in clinical practice, regulatory environments, and increased interest in drug repurposing. These trends are affecting manufacturing, distribution, and future potential of penfluridol.

United States: Penfluridol is not commonly approved or sold in the US. Current activity is mostly focused on the investigation of its repurposing potential in oncology, rather than on its original antipsychotic indication. The US market continues to be dominated by newer, long-acting injectables for schizophrenia.
China: China is a large producer and consumer of penfluridol, mainly for the treatment of schizophrenia. Recent news has involved regulatory approvals of new generic versions to expand availability and attempts by local producers to fulfill rising demand. In addition, research on the anti-tumor property of penfluridol has been conducted.
Germany: Penfluridol's presence in Germany is limited among other antipsychotics. Current trends emphasize its application to particular clinical niches in the case of treatment-resistant patients who have poor compliance with daily oral medication, sometimes based on clinical experience over years. Emphasis remains on more recently introduced and more commonly prescribed antipsychotics.
India: India is a key world supplier of penfluridol API and finished products, especially generic ones. Developments in recent times include the expansion of production capacity to satisfy international demand for its API and expanded domestic utilization, fueled by its cost-effectiveness and long-acting oral profile for schizophrenia treatment.
Japan: Penfluridol is represented in Japan with a special emphasis upon its long-lasting oral efficacy. New trends comprise continued clinical practice with its usage in schizophrenia as well as growth in interest within its use within the control of behavioral disturbances associated with dementia in line with a population in increased age.

Features of the Global Penfluridol Market

Market Size Estimates: Penfluridol market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Penfluridol market size by type, application, and region in terms of value ($B).
Regional Analysis: Penfluridol market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the penfluridol market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the penfluridol market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the penfluridol market by type (tablets and capsules), application (hospital, clinic, pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Penfluridol Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Tablets: Trends and Forecast (2019-2031)
4.4 Capsules: Trends and Forecast (2019-2031)

5. Global Penfluridol Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Hospital: Trends and Forecast (2019-2031)
5.4 Clinic: Trends and Forecast (2019-2031)
5.5 Pharmacy: Trends and Forecast (2019-2031)
5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Penfluridol Market by Region

7. North American Penfluridol Market

7.1 Overview
7.2 North American Penfluridol Market by Type
7.3 North American Penfluridol Market by Application
7.4 United States Penfluridol Market
7.5 Mexican Penfluridol Market
7.6 Canadian Penfluridol Market

8. European Penfluridol Market

8.1 Overview
8.2 European Penfluridol Market by Type
8.3 European Penfluridol Market by Application
8.4 German Penfluridol Market
8.5 French Penfluridol Market
8.6 Spanish Penfluridol Market
8.7 Italian Penfluridol Market
8.8 United Kingdom Penfluridol Market

9. APAC Penfluridol Market

9.1 Overview
9.2 APAC Penfluridol Market by Type
9.3 APAC Penfluridol Market by Application
9.4 Japanese Penfluridol Market
9.5 Indian Penfluridol Market
9.6 Chinese Penfluridol Market
9.7 South Korean Penfluridol Market
9.8 Indonesian Penfluridol Market

10. ROW Penfluridol Market

10.1 Overview
10.2 ROW Penfluridol Market by Type
10.3 ROW Penfluridol Market by Application
10.4 Middle Eastern Penfluridol Market
10.5 South American Penfluridol Market
10.6 African Penfluridol Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Penfluridol Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Hunan Dongting Pharm
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Jiangsu Nhwa Pharmaceutical
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Sphsine Pharm
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Chongqing Qingyang Pharmaceutical
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Kamp
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Harbin Pharmaceutical Group
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Fuhe Group
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.9 Hunan Zhongnan Pharm
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.10 Lifecare Neuro Products
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.11 Enomark
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

簡介目錄圖表

List of Figures

Figure 1.1: Trends and Forecast for the Global Penfluridol Market
Figure 2.1: Usage of Penfluridol Market
Figure 2.2: Classification of the Global Penfluridol Market
Figure 2.3: Supply Chain of the Global Penfluridol Market
Figure 2.4: Driver and Challenges of the Penfluridol Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global Penfluridol Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Penfluridol Market ($B) by Type
Figure 4.3: Forecast for the Global Penfluridol Market ($B) by Type
Figure 4.4: Trends and Forecast for Tablets in the Global Penfluridol Market (2019-2031)
Figure 4.5: Trends and Forecast for Capsules in the Global Penfluridol Market (2019-2031)
Figure 5.1: Global Penfluridol Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Penfluridol Market ($B) by Application
Figure 5.3: Forecast for the Global Penfluridol Market ($B) by Application
Figure 5.4: Trends and Forecast for Hospital in the Global Penfluridol Market (2019-2031)
Figure 5.5: Trends and Forecast for Clinic in the Global Penfluridol Market (2019-2031)
Figure 5.6: Trends and Forecast for Pharmacy in the Global Penfluridol Market (2019-2031)
Figure 5.7: Trends and Forecast for Others in the Global Penfluridol Market (2019-2031)
Figure 6.1: Trends of the Global Penfluridol Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Penfluridol Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Penfluridol Market (2019-2031)
Figure 7.2: North American Penfluridol Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Penfluridol Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Penfluridol Market ($B) by Type (2025-2031)
Figure 7.5: North American Penfluridol Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Penfluridol Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Penfluridol Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Penfluridol Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Penfluridol Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Penfluridol Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Penfluridol Market (2019-2031)
Figure 8.2: European Penfluridol Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Penfluridol Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Penfluridol Market ($B) by Type (2025-2031)
Figure 8.5: European Penfluridol Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Penfluridol Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Penfluridol Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Penfluridol Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Penfluridol Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Penfluridol Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Penfluridol Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Penfluridol Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Penfluridol Market (2019-2031)
Figure 9.2: APAC Penfluridol Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Penfluridol Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Penfluridol Market ($B) by Type (2025-2031)
Figure 9.5: APAC Penfluridol Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Penfluridol Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Penfluridol Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Penfluridol Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Penfluridol Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Penfluridol Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Penfluridol Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Penfluridol Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Penfluridol Market (2019-2031)
Figure 10.2: ROW Penfluridol Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Penfluridol Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Penfluridol Market ($B) by Type (2025-2031)
Figure 10.5: ROW Penfluridol Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Penfluridol Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Penfluridol Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Penfluridol Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Penfluridol Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Penfluridol Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Penfluridol Market
Figure 11.2: Market Share (%) of Top Players in the Global Penfluridol Market (2024)
Figure 12.1: Growth Opportunities for the Global Penfluridol Market by Type
Figure 12.2: Growth Opportunities for the Global Penfluridol Market by Application
Figure 12.3: Growth Opportunities for the Global Penfluridol Market by Region
Figure 12.4: Emerging Trends in the Global Penfluridol Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Penfluridol Market by Type and Application
Table 1.2: Attractiveness Analysis for the Penfluridol Market by Region
Table 1.3: Global Penfluridol Market Parameters and Attributes
Table 3.1: Trends of the Global Penfluridol Market (2019-2024)
Table 3.2: Forecast for the Global Penfluridol Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Penfluridol Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Penfluridol Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Penfluridol Market (2025-2031)
Table 4.4: Trends of Tablets in the Global Penfluridol Market (2019-2024)
Table 4.5: Forecast for Tablets in the Global Penfluridol Market (2025-2031)
Table 4.6: Trends of Capsules in the Global Penfluridol Market (2019-2024)
Table 4.7: Forecast for Capsules in the Global Penfluridol Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Penfluridol Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Penfluridol Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Penfluridol Market (2025-2031)
Table 5.4: Trends of Hospital in the Global Penfluridol Market (2019-2024)
Table 5.5: Forecast for Hospital in the Global Penfluridol Market (2025-2031)
Table 5.6: Trends of Clinic in the Global Penfluridol Market (2019-2024)
Table 5.7: Forecast for Clinic in the Global Penfluridol Market (2025-2031)
Table 5.8: Trends of Pharmacy in the Global Penfluridol Market (2019-2024)
Table 5.9: Forecast for Pharmacy in the Global Penfluridol Market (2025-2031)
Table 5.10: Trends of Others in the Global Penfluridol Market (2019-2024)
Table 5.11: Forecast for Others in the Global Penfluridol Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Penfluridol Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Penfluridol Market (2025-2031)
Table 7.1: Trends of the North American Penfluridol Market (2019-2024)
Table 7.2: Forecast for the North American Penfluridol Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Penfluridol Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Penfluridol Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Penfluridol Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Penfluridol Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Penfluridol Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Penfluridol Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Penfluridol Market (2019-2031)
Table 8.1: Trends of the European Penfluridol Market (2019-2024)
Table 8.2: Forecast for the European Penfluridol Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Penfluridol Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Penfluridol Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Penfluridol Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Penfluridol Market (2025-2031)
Table 8.7: Trends and Forecast for the German Penfluridol Market (2019-2031)
Table 8.8: Trends and Forecast for the French Penfluridol Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Penfluridol Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Penfluridol Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Penfluridol Market (2019-2031)
Table 9.1: Trends of the APAC Penfluridol Market (2019-2024)
Table 9.2: Forecast for the APAC Penfluridol Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Penfluridol Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Penfluridol Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Penfluridol Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Penfluridol Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Penfluridol Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Penfluridol Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Penfluridol Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Penfluridol Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Penfluridol Market (2019-2031)
Table 10.1: Trends of the ROW Penfluridol Market (2019-2024)
Table 10.2: Forecast for the ROW Penfluridol Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Penfluridol Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Penfluridol Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Penfluridol Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Penfluridol Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Penfluridol Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Penfluridol Market (2019-2031)
Table 10.9: Trends and Forecast for the African Penfluridol Market (2019-2031)
Table 11.1: Product Mapping of Penfluridol Suppliers Based on Segments
Table 11.2: Operational Integration of Penfluridol Manufacturers
Table 11.3: Rankings of Suppliers Based on Penfluridol Revenue
Table 12.1: New Product Launches by Major Penfluridol Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Penfluridol Market

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

五氟利多市場報告：2031 年趨勢、預測與競爭分析

Penfluridol Market Report: Trends, Forecast and Competitive Analysis to 2031

目錄

第1章執行摘要

第2章 市場概述

第3章：市場趨勢與預測分析

第4章 全球五氟利多市場（按類型）

第5章全球五氟利多市場應用

第6章區域分析

第7章北美五氟利多市場

第8章歐洲五氟利多市場

9. 亞太地區五氟利多市場

第10章 世界其他地區的 Penfleur 市場

第11章 競爭分析

第12章機會與策略分析

第13章：價值鏈主要企業的公司簡介

第14章 附錄